Galderma Group AG
176.70 CHF-3.95 (-2.19%)
ListedCHF42.1BHealthcareDrug Manufacturers - Specialty & Generic7,676 employees
Galderma Group AG is a Swiss healthcare company specializing exclusively in dermatology, headquartered in Zug and founded in 1981. The company focuses on skin health through three integrated business segments: injectable aesthetics, dermatological skincare, and therapeutic dermatology. In injectable aesthetics, Galderma Group AG offers physician-administered neuromodulators and dermal fillers under brands such as Dysport, Restylane, Sculptra, Azzalure and Alluzience, serving aesthetic clinics and medical professionals. Its dermatological skincare portfolio centers on consumer-facing brands like Cetaphil and ALASTIN, providing cleansers, moisturizers and targeted skincare solutions for sensitive and problem-prone skin. In therapeutic dermatology, the company markets prescription and non-prescription treatments for conditions including acne, rosacea and other inflammatory skin disorders, with brands such as Epiduo, Differin, Aklief, Oracea, Benzac and Loceryl. Galderma Group AG operates globally in around 90 countries, partnering closely with dermatologists and healthcare professionals to deliver science-based, premium products and services across the full spectrum of the dermatology market.
Total Cash (MRQ)
639.8M
Total Debt (MRQ)
2.26B
Current Ratio (MRQ)
1.19
Book Value / Share
28.36